Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Sell
34
TOVX Quote, Financials, Valuation and Earnings
Last price:
$1.22
Seasonality move
:
-9.97%
Day range:
$1.18 - $1.22
52-week range:
$1.03 - $13.62
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.59x
P/B ratio:
0.18x
Volume:
22.9K
Avg. volume:
42.4K
1-year change:
-90.3%
Market cap:
$3.4M
Revenue:
--
EPS (TTM):
-$26.66
Earnings Data
Next earnings date for TOVX
May 07
2025
Most recent earnings per share
-$1.60
Missed by $1.60
(Mar 6/2025)
Consensus Estimate
--
(Mar 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TOVX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/07/2025 | Q1 | -- | -- | -- | -- | -- |
| 03/06/2025 | Q4 | -- | -- | -$1.60 | -- | -- |
| 11/12/2024 | Q3 | -- | -- | -$6.81 | -$5.25 | -$1.56 |
| 08/13/2024 | Q2 | -- | -- | -$10.75 | -- | -- |
| 05/07/2024 | Q1 | -- | -- | -$7.50 | -$8.50 | $1.00 |
| 03/25/2024 | Q4 | -- | -- | -$8.12 | -$8.25 | $0.13 |
| 11/13/2023 | Q3 | -- | -- | -$4.85 | -$8.50 | $3.65 |
| 08/11/2023 | Q2 | -- | -- | -$8.50 | -$8.50 | -- |
| 05/16/2023 | Q1 | -- | -- | -$7.50 | -$8.00 | $0.50 |
| 03/16/2023 | Q4 | -- | -- | -$11.00 | -$8.00 | -$3.00 |
| 11/03/2022 | Q3 | -- | -- | -$7.50 | -- | -- |
| 08/11/2022 | Q2 | -- | -- | -$7.00 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$7.75 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$9.75 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$6.25 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$6.00 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$32.50 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$35.00 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$35.00 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$45.00 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$50.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$47.50 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$77.50 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$57.50 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$62.50 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$240.86 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$232.50 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$290.00 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$162.50 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | $192.50 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$1,225.00 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$262.50 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$175.00 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$177.37 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$799.33 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$875.01 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$1,050.02 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$1,058.00 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$1,050.02 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -$1,662.52 | -- | -- |
| 03/31/2015 | Q1 | -- | -- | -$1,487.52 | -- | -- |
Theriva Biologics Earnings Questions
-
How Much did Theriva Biologics Generate in Revenue Last Quarter?
Theriva Biologics reported -- worth of top line sales in its most recent quarter.
-
Did Theriva Biologics Beat Earnings Last Quarter?
Theriva Biologics announced earnings per share of -$1.60 which represents a miss of analyst forecast a -- per share.
-
Is Theriva Biologics Profitable?
Theriva Biologics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Theriva Biologics EPS Next Year?
Theriva Biologics's earnings are forecast to decrease from -$19.03 per share to -$23.75 per share next year representing a decrease of -16.61%.
-
When is Theriva Biologics's Earnings Date?
Theriva Biologics's next earnings date is May 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Is Shopify a Millionaire Maker?
Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
